AKT1 and gastric cancer: Consistently, TRIM24-induced chemoresistance to 5-FU can be reversed by the AKT inhibitor LY294002, suggesting a regulatory relationship between TRIM24 and AKT signaling, resulting in chemotherapy in gastric cancer cells [80].